Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.

C Taxonera; E Iglesias; F Muñoz; M Calvo; Acosta M Barreiro-de; D Busquets; X Calvet; A Rodríguez; R Pajares; JP Gisbert; P López-Serrano; JL Pérez-Calle; Á Ponferrada; la Coba C De; F Bermejo; M Chaparro; D Olivares; C Alba; I. Fernández-Blanco

doi:10.1007/s10620-016-4398-5

Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.

C Taxonera, E Iglesias, F Muñoz, M Calvo, Acosta M Barreiro-de, D Busquets, X Calvet, A Rodríguez, R Pajares, JP Gisbert, P López-Serrano, JL Pérez-Calle, Á Ponferrada, la Coba C De, F Bermejo, M Chaparro, D Olivares, C Alba, I. Fernández-Blanco

Department of Medicine

Research output: Contribution to journal › Article › Research

35 Citations (Scopus)

Original language	English
Pages (from-to)	481-490
Journal	Dig Dis Sci.
Volume	62
Issue number	2
DOIs	https://doi.org/10.1007/s10620-016-4398-5
Publication status	Published - 1 Jan 2017

Access to Document

10.1007/s10620-016-4398-5

Cite this

Taxonera, C., Iglesias, E., Muñoz, F., Calvo, M., Barreiro-de, A. M., Busquets, D., Calvet, X., Rodríguez, A., Pajares, R., Gisbert, JP., López-Serrano, P., Pérez-Calle, JL., Ponferrada, Á., De, L. C. C., Bermejo, F., Chaparro, M., Olivares, D., Alba, C., & Fernández-Blanco, I. (2017). Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation. Dig Dis Sci., 62(2), 481-490. https://doi.org/10.1007/s10620-016-4398-5

@article{e3596b99aab049c284eeef293c8457ca,

title = "Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.",

author = "C Taxonera and E Iglesias and F Mu{\~n}oz and M Calvo and Barreiro-de, {Acosta M} and D Busquets and X Calvet and A Rodr{\'i}guez and R Pajares and JP Gisbert and P L{\'o}pez-Serrano and JL P{\'e}rez-Calle and {\'A} Ponferrada and De, {la Coba C} and F Bermejo and M Chaparro and D Olivares and C Alba and I. Fern{\'a}ndez-Blanco",

year = "2017",

month = jan,

day = "1",

doi = "10.1007/s10620-016-4398-5",

language = "English",

volume = "62",

pages = "481--490",

journal = "Digestive Diseases and Sciences",

issn = "0163-2116",

publisher = "Springer New York",

number = "2",

}

Taxonera, C, Iglesias, E, Muñoz, F, Calvo, M, Barreiro-de, AM, Busquets, D, Calvet, X, Rodríguez, A, Pajares, R, Gisbert, JP, López-Serrano, P, Pérez-Calle, JL, Ponferrada, Á, De, LCC, Bermejo, F, Chaparro, M, Olivares, D, Alba, C & Fernández-Blanco, I 2017, 'Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.', Dig Dis Sci., vol. 62, no. 2, pp. 481-490. https://doi.org/10.1007/s10620-016-4398-5

TY - JOUR

T1 - Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.

AU - Taxonera, C

AU - Iglesias, E

AU - Muñoz, F

AU - Calvo, M

AU - Barreiro-de, Acosta M

AU - Busquets, D

AU - Calvet, X

AU - Rodríguez, A

AU - Pajares, R

AU - Gisbert, JP

AU - López-Serrano, P

AU - Pérez-Calle, JL

AU - Ponferrada, Á

AU - De, la Coba C

AU - Bermejo, F

AU - Chaparro, M

AU - Olivares, D

AU - Alba, C

AU - Fernández-Blanco, I.

PY - 2017/1/1

Y1 - 2017/1/1

U2 - 10.1007/s10620-016-4398-5

DO - 10.1007/s10620-016-4398-5

M3 - Article

SN - 0163-2116

VL - 62

SP - 481

EP - 490

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

IS - 2

ER -